McCartney2021_Article_VitaminDAndSARS-CoV-2Infection.pdf (1.4 MB)
Download fileVitamin D and SARS-CoV-2 infection - evolution of evidence supporting clinical practice and policy development : a position statement from the Covit-D Consortium
journal contribution
posted on 2022-03-30, 14:31 authored by Daniel M McCartney, Paula M O'Shea, John L Faul, Martin J Healy, Greg Byrne, Tomás P Griffin, James Bernard Walsh, Declan G Byrne, Rose Anne KennyVitamin D is a vitamin pro-hormone which can be taken exogenously from the diet or supplements, or can be synthesised cutaneously through the action of summer sunlight on skin as shown in Fig. 1 [1]. While oral intake is an important source of vitamin D, the major physiological source is UVB irradiation at a wavelength of 290–315 nm [2]. The ability of the skin to synthesise vitamin D is compromised at northerly latitudes, particularly amongst those who are older or who have dark skin pigmentation.
History
Comments
The original article is available at https://link.springer.com/Published Citation
McCartney DM, et al. Vitamin D and SARS-CoV-2 infection - evolution of evidence supporting clinical practice and policy development : a position statement from the Covit-D Consortium. Ir J Med Sci. 2020;190(3):1253-1265.Publication Date
21 November 2020External DOI
PubMed ID
33219912Department/Unit
- Medicine
Publisher
Springer Nature.Version
- Published Version (Version of Record)